CN104427979B - 具有特定的取代基分布的酯化的纤维素醚 - Google Patents

具有特定的取代基分布的酯化的纤维素醚 Download PDF

Info

Publication number
CN104427979B
CN104427979B CN201280072177.1A CN201280072177A CN104427979B CN 104427979 B CN104427979 B CN 104427979B CN 201280072177 A CN201280072177 A CN 201280072177A CN 104427979 B CN104427979 B CN 104427979B
Authority
CN
China
Prior art keywords
methyl
groups
hydroxypropyl
glucoside unit
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201280072177.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN104427979A (zh
Inventor
R·L·施米特
R·L·萨姆勒
M·布拉克哈根
O·彼得曼
R·阿登
N·S·格拉斯曼
S·J·吉劳多
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Global Technologies LLC
Original Assignee
Dow Global Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47146713&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN104427979(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dow Global Technologies LLC filed Critical Dow Global Technologies LLC
Publication of CN104427979A publication Critical patent/CN104427979A/zh
Application granted granted Critical
Publication of CN104427979B publication Critical patent/CN104427979B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B13/00—Preparation of cellulose ether-esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
CN201280072177.1A 2012-04-11 2012-10-24 具有特定的取代基分布的酯化的纤维素醚 Expired - Fee Related CN104427979B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261622754P 2012-04-11 2012-04-11
US61/622,754 2012-04-11
PCT/US2012/061586 WO2013154607A1 (en) 2012-04-11 2012-10-24 Esterified cellulose ethers having a specific substituent distribution

Publications (2)

Publication Number Publication Date
CN104427979A CN104427979A (zh) 2015-03-18
CN104427979B true CN104427979B (zh) 2018-02-16

Family

ID=47146713

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280072177.1A Expired - Fee Related CN104427979B (zh) 2012-04-11 2012-10-24 具有特定的取代基分布的酯化的纤维素醚

Country Status (6)

Country Link
US (1) US9320799B2 (cg-RX-API-DMAC7.html)
EP (1) EP2836205B1 (cg-RX-API-DMAC7.html)
JP (1) JP6133969B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140146181A (cg-RX-API-DMAC7.html)
CN (1) CN104427979B (cg-RX-API-DMAC7.html)
WO (1) WO2013154607A1 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX363722B (es) 2013-03-01 2019-03-29 Hercules Inc Composiciones farmaceuticas con rendimiento mejorado y capacidad de procesamiento mejorada.
EP2964204B1 (en) * 2013-03-07 2017-01-04 Dow Global Technologies LLC Novel esterified cellulose ethers of very low viscosity
JP6334574B2 (ja) * 2013-03-07 2018-05-30 ダウ グローバル テクノロジーズ エルエルシー 新規の超高分子量のエステル化セルロースエーテル
CN105164162B (zh) * 2013-05-14 2017-11-28 陶氏环球技术有限责任公司 用二羧酸酯化的纤维素醚
KR102286952B1 (ko) 2013-12-31 2021-08-09 롯데정밀화학 주식회사 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말
EP3107940B1 (en) * 2014-02-20 2019-08-07 Dow Global Technologies LLC Novel esterified cellulose ethers of high molecular weight and homogeneity
US10179110B2 (en) * 2014-05-20 2019-01-15 Dow Global Technologies Llc Dispersion comprising a partially neutralized esterified cellulose ether
MX2017002073A (es) 2014-08-27 2017-05-25 Dow Global Technologies Llc Eteres de celulosa esterificados con bajo contenido insoluble en acetona.
JP6203702B2 (ja) 2014-11-18 2017-09-27 信越化学工業株式会社 ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法
JP6295380B2 (ja) * 2015-03-16 2018-03-14 ダウ グローバル テクノロジーズ エルエルシー 脂肪族カルボン酸の存在下でエステル化セルロースエーテルを調製するためのプロセス
KR20170128355A (ko) * 2015-03-16 2017-11-22 다우 글로벌 테크놀로지스 엘엘씨 에스테르화 셀룰로오스 에테르의 겔화
JP6356922B2 (ja) * 2015-03-16 2018-07-11 ダウ グローバル テクノロジーズ エルエルシー 低い中和度を有する水溶性エステル化セルロースエーテル
BR112017018232A2 (pt) * 2015-03-16 2018-04-17 Dow Global Technologies Llc éteres de celulose esterificados solúveis em água
JP6371482B2 (ja) * 2015-03-16 2018-08-08 ダウ グローバル テクノロジーズ エルエルシー エステル化セルロースエーテルの水溶液
KR20180008524A (ko) * 2015-05-15 2018-01-24 다우 글로벌 테크놀로지스 엘엘씨 초고분자량 및 저점도의 에스테르화된 셀룰로오스 에테르의 제조 방법
WO2016196153A1 (en) * 2015-06-05 2016-12-08 Dow Global Technologies Llc Cellulose ether powders
CN107636018B (zh) * 2015-06-05 2020-07-10 陶氏环球技术有限责任公司 纤维素醚粉末
WO2017053337A1 (en) * 2015-09-24 2017-03-30 Dow Global Technologies Llc Process for preparing an ester of a cellulose ether in the presence of acetic acid and a reaction catalyst
CN108026184B (zh) * 2015-10-02 2020-09-15 陶氏环球技术有限责任公司 包含分散的酯化纤维素醚的水性组合物
US9884922B2 (en) 2016-03-11 2018-02-06 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate, method for producing the same and composition containing the same
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
KR20190125334A (ko) * 2017-03-17 2019-11-06 다우 글로벌 테크놀로지스 엘엘씨 반응 생성 혼합물로부터 에스테르화 셀룰로스 에테르를 회수하는 공정
KR102719143B1 (ko) * 2017-08-16 2024-10-21 뉴트리션 ＆ 바이오사이언시즈 유에스에이 1, 엘엘씨 저분자량 셀룰로오스 에테르의 제어된 제조 방법
JP7526727B2 (ja) * 2018-12-18 2024-08-01 ニュートリション アンド バイオサイエンシズ ユーエスエー １，リミティド ライアビリティ カンパニー ヒドロキシアルキルメチルセルロースを含む徐放性組成物
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
JP7128782B2 (ja) * 2019-08-09 2022-08-31 信越化学工業株式会社 エアゾール食品用組成物、ヒドロキシプロピルメチルセルロース及びヒドロキシプロピルメチルセルロースの製造方法
CN112704671B (zh) * 2020-12-28 2022-04-19 普洛药业股份有限公司 一种阿莫西林克拉维酸钾胶囊及其制备方法
WO2023023424A1 (en) 2021-08-19 2023-02-23 Phenom Pharmaceuticals, Inc. Compositions and methods for treatment of sars cov-2
US20240360250A1 (en) * 2021-08-26 2024-10-31 Nutrition & Biosciences Usa 1, Llc Novel hydroxyalkyl methylcellulose and its use
CN114805787B (zh) * 2022-02-24 2023-09-12 南京林业大学 一种纤维素基聚醚多元醇脂肪酸酯增塑剂及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115330A2 (en) * 2004-05-28 2005-12-08 Pfizer Products Inc. Pharmaceutical compositions with enhanced performance

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435027A (en) 1965-12-13 1969-03-25 Hercules Inc Cellulose ether-esters and process
US4226981A (en) 1977-09-28 1980-10-07 Shin-Etsu Chemical Co., Ltd. Ether-ester derivatives of cellulose and their applications
DE2917104A1 (de) 1979-04-27 1980-11-06 Hoechst Ag Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung
US4365060A (en) 1979-04-28 1982-12-21 Shin-Etsu Chemical Co. Ltd. Enterosoluble capsules
JPS6225101A (ja) 1985-07-24 1987-02-03 Shin Etsu Chem Co Ltd 低重合度セルロ−スエ−テルの製造方法
JPS6281402A (ja) 1985-10-07 1987-04-14 Shin Etsu Chem Co Ltd セルロ−スエ−テル酸性ジカルボン酸エステルの製造方法
JP2916238B2 (ja) * 1990-10-16 1999-07-05 旭化成工業株式会社 アルキルセルロースの製造方法
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
JP3002916B2 (ja) * 1991-10-29 2000-01-24 ダイセル化学工業株式会社 セルロース混合エーテルの製造法
JP2872951B2 (ja) * 1995-11-07 1999-03-24 第一工業製薬株式会社 カルボキシメチルセルロースナトリウム塩
JP3996653B2 (ja) * 1996-01-26 2007-10-24 信越化学工業株式会社 置換度分布が制御されたヒドロキシプロピルセルロース
US6261218B1 (en) 1998-12-01 2001-07-17 The Dow Chemical Company Process and apparatus for making low molecular weight cellulose ethers
DE10141680B4 (de) 2001-08-25 2004-02-26 Clariant Gmbh Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern
JP2011074113A (ja) * 2009-09-29 2011-04-14 Toray Ind Inc セルロース混合エステルおよびその製造方法
WO2011159626A1 (en) 2010-06-14 2011-12-22 Bend Research, Inc. Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
US20160228559A1 (en) 2013-09-25 2016-08-11 Dow Global Technologies Llc Composition for application to a mucosa comprising a cellulose ether

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115330A2 (en) * 2004-05-28 2005-12-08 Pfizer Products Inc. Pharmaceutical compositions with enhanced performance

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Analysis of the substituent distribution in the glucosyl units and along the polymer chain of hydroxypropylmethyl celluloses and statistical evaluation;Roland Adden et.al;《Cellulose》;20061231;第13卷;459–476 *

Also Published As

Publication number Publication date
EP2836205B1 (en) 2016-10-19
KR20140146181A (ko) 2014-12-24
US9320799B2 (en) 2016-04-26
WO2013154607A1 (en) 2013-10-17
EP2836205A1 (en) 2015-02-18
CN104427979A (zh) 2015-03-18
JP2015521209A (ja) 2015-07-27
US20150065547A1 (en) 2015-03-05
JP6133969B2 (ja) 2017-05-24

Similar Documents

Publication Publication Date Title
CN104427979B (zh) 具有特定的取代基分布的酯化的纤维素醚
CN105899542B (zh) 新颖低粘度酯化纤维素醚
CN105007903B (zh) 具有极高分子量的酯化纤维素醚
CN105026435B (zh) 具有低粘度和高分子量的新颖酯化纤维素醚
JP6224712B2 (ja) 高分子量および均一性の新規エステル化セルロースエーテル
JP6185559B2 (ja) 有機希釈剤およびセルロースエーテルを含む組成物
CN105025887B (zh) 新颖极低粘度酯化纤维素醚
JP6224711B2 (ja) 部分架橋結合型エステル化セルロースエーテル
CN105992773B (zh) 具有高分子量和均质性的酯化纤维素醚
JP6353061B2 (ja) 有機液体希釈剤及び特定のヒドロキシアルキルメチルセルロースを含む組成物
KR20180008524A (ko) 초고분자량 및 저점도의 에스테르화된 셀룰로오스 에테르의 제조 방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180216

Termination date: 20191024

CF01 Termination of patent right due to non-payment of annual fee